There are other companies that are challenging this issue, but what differs us is: progressive regulatory regime in the Republic of Belarus provides access to an extensive dataset and quick market entry (monetization started in 1 year after launch)
Support of the Ministry of Healthcare of the Republic of Belarus. Studies of a unique genetic landscape are important for big pharmaceutical companies
- Fast iteration, fast release delivery
- Extensions for veterinary medicine
- Low burn rate
- Extensions for veterinary medicine
- Advisory support of the top experts